The scale of the problem
Obesity is a major global health challenge. The proportion of adults who are overweight or obese has increased substantially
over the past 30 years, and there have been no reports of “success stories” from any nation during this time.1 In New
Zealand, it is estimated that over one-third of adults are obese – this includes nearly one-half of Māori and over two-thirds
of Pacific peoples.2
There have been many major studies on lifestyle interventions to aid with weight management and diabetes prevention,
along with findings from “real life” programmes in the community. However, there is little evidence that these interventions
result in large-scale (i.e. population level), long-term improvements in weight loss (and maintenance) or metabolic health
indicators, such as type 2 diabetes.1, 3, 4
This raises the questions of whether researchers and clinicians have the biology of human physiology, nutrition and
physical activity basics correct and/or whether the socioeconomic environment is just too difficult to get people to change
to healthier lifestyles. There is evidence that both issues have played a part in nations failing to improve normal weight
maintenance and metabolic management for their populations.
How the ABO programme can make a difference
The WBOPPHO programme adopts a sympathetic approach to weight management that helps patients understand how our obesogenic
society, via aggressive marketing, promotes the consumption of energy-dense food. Through the weight management programme,
people are given planning advice so they can find time in their busy lives to overcome their obesogenic environment and
regularly eat healthy and nutritious food.
The basis for the dietary advice provided by the ABO programme is evidence that populations that consume large quantities
of unprocessed, high-nutrient foods have good metabolic health and central weight management.5, 6 An important part of
the programme is that health professionals acknowledge that people often find it difficult to choose to eat these high-nutrient
foods as they prefer refined, energy-dense food.7 Health professionals are encouraged to think of this preference for
energy-dense food as a type of “addiction”; this approach highlights similarities with how smoking cessation is being
managed in primary care.
Overcoming barriers to weight-loss interventions
A key part of the weight management programme is to help health professionals overcome barriers to discussing weight-
or diet-related issues with patients.
These barriers include:
- Fear of offending patients
- Discomfort at bringing up the issue of weight if the health professional themselves is overweight
- Not being able to offer a service due to lack of knowledge
In order to provide a non-judgemental opportunity for people to discuss issues relating to weight or body shape, it
is important that all patients, of any size, can be weighed and measured during the consultation. This may necessitate
purchasing a new set of scales, particularly in communities with large numbers of Māori and Pacific peoples who have some
of the highest rates of morbid obesity (BMI >40 kg/m2 ) and super obesity (BMI >55 kg/m2 ) in the world.8
Asking patients if they have any concerns about weight management
Health professionals can initiate discussions with patients about body weight or dietary patterns by asking one or two
open-ended questions to identify if the patient has any concerns. For example, “How do you feel about
your body shape?”,
or “Are you happy with your diet or eating patterns at the moment?” Patients who demonstrate a willingness to discuss
body weight or diet-related issues should then be encouraged to do so using open, non-judgemental, reflective questions;
the focus should be on making the patient feel heard.
Patients who are struggling with weight-related issues need to know that they are not alone, and that many other people
are confronting the same problems. Talking about how society creates an obesogenic environment with prominent advertising
and the ready availability of energy-dense food is likely to reduce any sense of isolation felt by these patients.
During the “Ask” phase of the intervention health professionals assess the patient’s current consumption of plant based,
nutrient dense foods, such as vegetables, fruit and nuts, using validated questions.
Giving brief advice
The main dietary advice provided by the intervention is to encourage people to increase their intake of fruit and vegetables
(limiting high-starch vegetables such as potato). The goal is for these healthy forms of food to eventually replace “addictive”
energy-dense foods. Calorie counting or weighing food is not part of the intervention as this may be perceived by the
patient as being negative. A guiding, partnering approach is adopted in order to develop a management plan for the patient,
as opposed to a “telling” approach.
A reduction in sedentary activities and an increase in the frequency and volume of physical activity is strongly recommended
to all patients.
During the consultation an offer of annual weight, height, waist and hip measurements should be made, if these are not
already being recorded. The patient is also offered routine blood tests, e.g. lipid profile, and then asked to return
for a follow-up consultation to construct a plan for weight management and ongoing support.
Offering ongoing support or onward referral
Health professionals need to individualise weight-loss support according to patient requirements. For some patients
dietary and exercise advice, along with a plan to maintain high levels of fruit and vegetable intake is sufficient. For
other patients cognitive behavioural techniques are required to encourage patients to maintain healthy lifestyle changes.
Patients are contacted with reminders to attend quarterly follow-up consultations to encourage them to adhere to agreed
Pharmacological assistance may be appropriate for some patients
Patients who are obese, i.e. a body mass index (BMI) > 30 kg/m2 , who are unable to achieve clinically significant
weight-loss through diet and physical activity alone, may benefit from taking an anti-obesity medicine. None of these
medications are currently funded in New Zealand.
Phentermine is a medicine that has not been extensively studied, despite it having a long history as an anti-obesity
medicine. There have been concerns about the addictive potential of phentermine, as it is derived from an amphetamine
base.9 There have also been concerns raised about phentermine because of an association with other anti-obesity medicines
that have been previously withdrawn from the market due to their potential for causing cardiovascular and psychological
adverse effects.9, 10 Current anti-obesity medicine combinations, such as phentermine + topiramate or phentermine + lorcaserin,
which are available overseas, continue to be widely studied and research indicates that adverse effects due to phentermine
are unlikely to be a problem short- or long-term in these medicine combinations.11, 12, 13
Orlistat, a lipase inhibitor that blocks intestinal fat absorption, can produce modest weight loss in patients who have
a high-fat diet.
Metformin may be an appropriate medicine for people who are overweight and who also have raised HbA1c levels. Metformin
is thought to counteract central obesity by normalising metabolism and is recommended for use in the treatment of people
with intermediate hyperglycaemia (HbA1c 41 – 49 mmol/mol) in New Zealand,14 however, it is not approved for use as an
For further information see: “Managing
patients who are obese: a growing problem for primary care”.
Referral may be appropriate for patients with psychological issues
If a patient is suspected of having an obsessive-compulsive eating disorder (e.g. binge eating or bulimia), or delusional
shape/weight thoughts (e.g. anorexia), they should be referred to a psychiatrist, psychologist or health professional
with expertise in eating disorders. Fluoxetine is known to reduce binge eating, and is also associated with weight loss.
Fluoxetine may be a treatment option for patients who are obese and who also have a mood disorder.15, 16
The support material provided with the weight management programme includes contact details of community and culturally
appropriate health professionals who are able to provide assistance to patients with issues relating to the psychological,
social, dietary and physical fitness requirements.
For further information or questions about the ABO programme, contact Dr Anne-Thea McGill: